6/27/26
MOLINA HEALTHCARE (MOH) Thesis: The market is increasingly concerned about potential regulatory changes that could negatively impact Molina's reimbursement rates, overshadowing recent operational improvements.
★ Analysts see FY2027 revenue reaching $47.9B — +8.0% growth in a single year.
What Moves the Stock 1 Changes in Medicaid enrollment levels, particularly in states with expanding programs 2 Regulatory changes impacting reimbursement rates for Medicare and Medicaid 3 Operational efficiency improvements, particularly in medical loss ratios 4 Market share gains in key states through acquisitions or organic growth 5 Medicaid services - approximately 75% of total revenue 6 Medicare services - approximately 20% of total revenue 7 Marketplace services - approximately 5% of total revenue 8 Expansion of telehealth services in response to consumer demand 116 146 176 206 236 229.74 MOH Daily 229.74 Feb '26 Mar '26 May '26 Jun '26
My Notes "Management noted, 'While we are making strides in operational efficiency, we must remain vigilant about the regulatory landscape.'" Moat: Molina's deep integration with state Medicaid programs provides a durable competitive advantage, but it is vulnerable to regulatory changes. value - the stock is currently undervalued based on its low Price/Sales ratio of 0.2x… Molina's financing costs are influenced by interest rates, particularly as it may rely on debt for acquisitions or operational funding. Watch on earnings: Medicaid enrollment numbers, Medical loss ratio (MLR), Operating margin. One Sentence Summary: Molina Healthcare: the story is balanced — changes in medicaid enrollment levels, particularly in states with expanding programs.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.